PubMed HealthSearch

Biomedical subjects

B Hodgson

Publications and source records attributed to B Hodgson.

4 recordsLinked to original sources

Side-room tests to screen for microalbuminuria in diabetes mellitus.

Three side-room tests (latex bead immunoagglutination test, LBT; 25% sulphosalicylic acid test, SST; microalbutest, MAT) for the detection of microalbuminuria in diabetics are described and their screening potential and practicability assessed. One hundred insulin-dependent diabetics attending a diabetic clinic provided an early morning urine sample (Albustix-negative) which was subjected to each of the three tests, and urinary albumin concentration (UA) was assayed by RIA. Tests were assessed in random order by two trained operators using a semiquantitative grading scale with 100% concordance between 10 observers. All test results greater than or equal to trace +ve were sufficiently sensitive (sensitivity greater than or equal to 90%) in detecting UA greater than 15 mg/l, but MAT exhibited a significantly reduced specificity (69%) and positive predictive value (58%). For a reference UA greater than 30 mg/l, LBT and SST results greater than or equal to trace +ve and MAT results greater than or equal to +ve showed a sensitivity of 100%, a specificity greater than 85% and a positive predictive value greater than 60%. Reagent shelf-life was shortest with LBT. SST involved centrifugation or filtration. Technical skill required was highest with LBT and lowest with MAT. Costs were slightly higher with LBT than SST and were not available for MAT.

Albuminuria

Lysine- and lysine-plus-threonine-inhibitable aspartokinases in Bacillus brevis.

Two aspartokinase (ATP:L-aspartate 4-phosphotrasferase, EC 2.7.2.4) enzyme activities have been identified and partially purified from Bacillus brevis. Aspartokinase I is subject to both inhibition and repression by lysine, and has a molecular weight in the region of 110 000. Aspartokinase II is a lysine-stabilised enzyme, inhibited multivalently by lysine plus theonine and has a molecular weight in the region of 95 000. This attern of aspartokinase activity has not been described previously and is unusual in that one end product (lysine) regulates two isoenzymes catalysing the first reaction of a branced biosynthetic pathway. In the absence of lysine, aspartokinase II changes to a more unstable non-inhibitable enzyme. Both enzymes are stabilised by sulphydryl reducing agents and have similar affinities for ATP, aspartate and lysine. However, there is no evidence for a view that they are products of a common gene. Problem concerned with the regulation of aspartokinase activities in Bacillus species are discussed.

Aspartate Kinase

Effect of prostaglandin E2 on oviductal adenosine 3':5'-monophosphate levels during estrus and pseudopregnancy.

The basal levels of adenosine 3':5'-monophosphate (cyclic AMP) in the oviductal isthmus were lower during pseudopregnancy than during estrus. No differences were observed in the ampulla. Prostaglandin E2(PGE2) significantly increased cyclic AMP levels in the isthmus during pseudopregnancy but not during estrus. In contrast, in the ampulla, PGE2 did not alter cyclic AMP levels in either hormonal condition. Theophylline increased cyclic AMP levels in the isthmus and in the ampulla during pseudopregnancy. These results show that PGE2 causes a specific increase in cyclic AMP levels in the isthmus after ovulation.

Adenosine Monophosphate